Collegium Announces $25M Accelerated Share Repurchase Program
Portfolio Pulse from Benzinga Newsdesk
Collegium Pharmaceutical, Inc. has announced a $25 million accelerated share repurchase (ASR) program. The ASR is expected to be funded from the company's existing cash on hand.

November 09, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Collegium's announcement of a $25M ASR program could potentially boost investor confidence and increase the stock's demand, leading to a short-term price increase.
Accelerated share repurchase programs are often seen as a sign of a company's confidence in its own stock. By buying back its own shares, Collegium is reducing the number of shares available in the market, which could potentially increase the stock's price due to increased demand. This could boost investor confidence and lead to a short-term price increase.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100